Russell Odegard

Russ Odegard

Russell D. Odegard MBA, BS is an executive with more than 30 years of experience in the medical-diagnostic, life sciences, and pharmaceutical industries. In his career, he has launched more than 700 products globally, led multi-functional teams, and executed effective quality improvement processes.

In 2003 Mr. Odegard co-founded St. Louis–based DYNALABS, one of the fastest growing analytical lab testing services in the US, where he currently serves as an Executive Advisor. As part of the company’s executive team, he is responsible for its strategic direction, which emphasizes identifying, developing, and launching services that are centered on helping hospital and compounding pharmacies surpass their patient safety goals.

Prior to his time at DYNALABS, Mr. Odegard worked in research, product development, and quality management at enterprises such as Sigma-Aldrich, a chemical, life science, and biotechnology company owned by Merck KGaA, and Sigma Diagnostics, a medical diagnostics company. Mr. Odegard began his career in the life sciences industry working as a research scientist at the University of Alberta’s J.S. McEachern Cancer Research Unit.

Mr. Odegard is a frequent speaker on topics that impact¬¬ the compounding industry and has presented at the annual meetings of the International Academy of Compounding Pharmacists (IACP)—Compounders on Capitol Hill and the Compound Conference—and at meetings of the California Pharmacists Association and the California Council for the Advancement of Pharmacy.

Mr. Odegard is a member of the Financial Advisory Board of the University of Missouri in St. Louis and is often invited to speak to students at local academic institutions: Washington University, St. Louis College of Pharmacy, Fontbonne University, and the University of Missouri.

He received his bachelor of science degree in microbiology at the University of Alberta in Canada and his master’s degree in business administration at the University of Missouri, St. Louis.